-
(1S,13R)-1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol
-
ChemBase ID:
176445
-
Molecular Formular:
C22H27NO
-
Molecular Mass:
321.45588
-
Monoisotopic Mass:
321.20926449
-
SMILES and InChIs
SMILES:
c1(cc2c(cc1)CC1[C@@H]([C@@]2(CCN1CCc1ccccc1)C)C)O
Canonical SMILES:
Oc1ccc2c(c1)[C@@]1(C)CCN(C(C2)[C@@H]1C)CCc1ccccc1
InChI:
InChI=1S/C22H27NO/c1-16-21-14-18-8-9-19(24)15-20(18)22(16,2)11-13-23(21)12-10-17-6-4-3-5-7-17/h3-9,15-16,21,24H,10-14H2,1-2H3/t16-,21?,22-/m0/s1
InChIKey:
ZQHYKVKNPWDQSL-URJRECBDSA-N
-
Cite this record
CBID:176445 http://www.chembase.cn/molecule-176445.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(1S,13R)-1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol
|
|
|
IUPAC Traditional name
|
(1S,13R)-1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol
|
|
|
Synonyms
|
1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(2-phenylethyl)-2,6-methano-3-benzazocin-8-ol
|
1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-phenethyl-2,6-methano-3-benzazocin-8-ol
|
2'-Hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan
|
Phenethylazocine
|
Phenobenzorphan
|
Phenazocine
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
9.964461
|
H Acceptors
|
2
|
H Donor
|
1
|
LogD (pH = 5.5)
|
1.4474213
|
LogD (pH = 7.4)
|
1.9716463
|
Log P
|
4.0765004
|
Molar Refractivity
|
100.0487 cm3
|
Polarizability
|
38.829456 Å3
|
Polar Surface Area
|
23.47 Å2
|
Rotatable Bonds
|
3
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
P295400
|
Phenazocine is an opioid analgesic drug related to Pentazocine (P274300) and has a similar profile of effects. The use of Phenazocine results in analgesia and euphoria and in some cases dysphoria and hallucinations at high doses, most likely due to action |
PATENTS
PATENTS
PubChem Patent
Google Patent